Detalhe da pesquisa
1.
Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors.
JCO Glob Oncol
; 10: e2300011, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237094
2.
Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential.
Cancers (Basel)
; 16(1)2023 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201551
3.
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Target Oncol
; 18(3): 425-440, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017806
4.
Integration of artificial intelligence and precision oncology in Latin America.
Front Med Technol
; 4: 1007822, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36311461
5.
Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question.
Pharmaceutics
; 14(6)2022 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35745815
6.
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP).
Front Oncol
; 12: 904800, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903685
7.
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).
Clin Lung Cancer
; 23(6): 522-531, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798634
8.
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).
Lung Cancer
; 170: 114-121, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35753125
9.
Lung Cancer in Colombia.
J Thorac Oncol
; 17(8): 953-960, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717323